Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats

Journal of the Science of Food and Agriculture

Volumn 90, Issue 3, 2010, Pages 450-455

  Shin, Jang Woo ^a   Wang, Jing Hua ^b   Kang, Jong Koo ^b   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Antioxidant; Caffeine; Coffee; Dimethylnitrosamine; Kupffer cells

Indexed keywords

ANTIOXIDANT; CYTOKINE; DIMETHYLNITROSAMINE; HYDROXYPROLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; NITRIC OXIDE; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COFFEE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; LIVER; LIVER CIRRHOSIS; MACROPHAGE; MALE; METABOLISM; NECROSIS; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY; PLANT SEED; RAT; SPRAGUE DAWLEY RAT; STELLATE CELL;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; COFFEA; COFFEE; CYTOKINES; DIMETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEPATIC STELLATE CELLS; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MALE; MALONDIALDEHYDE; NECROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

RATTUS;

EID: 73349138301     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.3838     Document Type: Article

References (31)

1. Kung HC, Hoyert DL, Xu J and Murphy SL, Deaths: final data for 2005. Natl Health Stat Report 56:1-120 (2008).
2. Fowell AJ and Iredale JP, Emerging therapies for liver fibrosis. Dig Dis 24:174-183 (2006).
3. Henderson NC and Iredale JP, Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci 112:265-280 (2007)
4. Pinzani M, Rombouts K and Colagrande S, Fibrosis in chronic liver diseases:diagnosisandmanagement.JHepatol 42:S22-S36 (2005)
5. Corrao G, Zambon A, Bagnardi V, D'Amicis A and Klatsky A, Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 11:458-465 (2001).
6. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, et al, Does coffee protect against hepatocellular carcinoma? Br J Cancer 87:956-959 (2002).
7. Klatsky AL, Morton C, Udaltsova N and Friedman GD, Coffee, cirrhosis, andtransaminaseenzymes.ArchInternMed 166:1190-1195(2006)
8. Ruhl CE and Everhart JE, Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129:1928-1936 (2005).
9. Tverdal A and Skurtveit S, Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 13:419-423 (2003).
10. Chan ES, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, et al, AdenosineA(2A)receptorsplayaroleinthepathogenesisofhepatic cirrhosis. Br J Pharmacol 148:1144-1455 (2006).
11. Vinson JA, Coffee and cirrhosis: active ingredients? Arch Intern Med 166:2404-2405 (2006).
12. Research Council, Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC (1996).
13. Bedossa P and Poynard T, An algorithm for the grading of activity in chronic hepatitis C. The METAVIRA Cooperative Study Group. Hepatology 24:289-293 (1996).
14. Fujita M, Shannon JM, Morikawa O, Gauldie J, Hara N and Mason RJ, Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. Am J Respir Cell Mol Biol 29:669-676 (2003)
15. Mihara M and Uchiyama M, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271-278 (1978).
16. Ellman GL, Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77 (1959).
17. Beers RF and Siezer IW, A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133-140 (1952).
18. Cadden IS, Partovi N and Yoshida EM, Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 26:1-8 (2007).
19. Bataller R and Brenner DA, Liver fibrosis. J Clin Invest 115:209-218 (2005).
20. Kershenobich SD and Weissbrod AB, Liver fibrosis and inflammation. Ann Hepatol 2:159-163 (2003).
21. Kisseleva T and Brenner DA, Mechanisms of fibrogenesis. Exp Biol Med 233:109-122 (2008).
22. Albano E, Oxidative mechanismsin the pathogenesisof alcoholic liver disease. Mol Aspects Med 29:9-16 (2008).
23. Bondini S and Younossi ZM, Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol 52:135-143 (2006).
24. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G and Tiribelli C, Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14:72-81 (2008).
25. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, et al, NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112:1383-1394 (2003).
26. Svegliati-Baroni G, Saccomanno S, van Goor H, Jansen P, Benedetti A and Moshage H, Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 21:1-12 (2001).
27. Breitkopf K, Godoy P, Ciuclan L, Singer MV and Dooley S, TGF-beta/Smad signaling in the injured liver. Z Gastroenterol 44:57-66 (2006).
28. Friedman SL, Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669 (2008).
29. Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, et al, Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46:1509-1518 (2007)
30. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al, Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27:438-443 (1998).
31. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al, TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324-1332 (2007).